Global Drug Safety and Pharmacovigilance Service Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Drug Safety and Pharmacovigilance Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug Safety and Pharmacovigilance Service players cover BioPoint, Cmed, Drug Safety Solutions, Hilbrans and Orbis Clinical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug Safety and Pharmacovigilance Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug Safety and Pharmacovigilance Service market, with both quantitative and qualitative data, to help readers understand how the Drug Safety and Pharmacovigilance Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug Safety and Pharmacovigilance Service market and forecasts the market size by Type (Drug Safety Service and Drug Pharmacovigilance Service,), by Application (Experimental Stage, Clinical Stage, Postmarketing Stage and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Drug Safety and Pharmacovigilance Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug Safety and Pharmacovigilance Service market size and CAGR, Drug Safety and Pharmacovigilance Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug Safety and Pharmacovigilance Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug Safety and Pharmacovigilance Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug Safety and Pharmacovigilance Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including BioPoint, Cmed, Drug Safety Solutions, Hilbrans, Orbis Clinical, Parexel, PharmaLex, ProPharma and SGS, etc.
Chapter 14: Research Findings and Conclusion
The global market for Drug Safety and Pharmacovigilance Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug Safety and Pharmacovigilance Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug Safety and Pharmacovigilance Service players cover BioPoint, Cmed, Drug Safety Solutions, Hilbrans and Orbis Clinical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug Safety and Pharmacovigilance Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug Safety and Pharmacovigilance Service market, with both quantitative and qualitative data, to help readers understand how the Drug Safety and Pharmacovigilance Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug Safety and Pharmacovigilance Service market and forecasts the market size by Type (Drug Safety Service and Drug Pharmacovigilance Service,), by Application (Experimental Stage, Clinical Stage, Postmarketing Stage and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Drug Safety Service
- Drug Pharmacovigilance Service
- Experimental Stage
- Clinical Stage
- Postmarketing Stage
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioPoint
- Cmed
- Drug Safety Solutions
- Hilbrans
- Orbis Clinical
- Parexel
- PharmaLex
- ProPharma
- SGS
- SJ Pharma Consulting LLC
- Vitrana
- X7 Research
Chapter 1: Scope of Drug Safety and Pharmacovigilance Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug Safety and Pharmacovigilance Service market size and CAGR, Drug Safety and Pharmacovigilance Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug Safety and Pharmacovigilance Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug Safety and Pharmacovigilance Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug Safety and Pharmacovigilance Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including BioPoint, Cmed, Drug Safety Solutions, Hilbrans, Orbis Clinical, Parexel, PharmaLex, ProPharma and SGS, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Safety and Pharmacovigilance Service Market Size 2017-2028
2.1.2 Drug Safety and Pharmacovigilance Service Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Safety and Pharmacovigilance Service Segment by Type
2.2.1 Drug Safety Service
2.2.2 Drug Pharmacovigilance Service
2.3 Drug Safety and Pharmacovigilance Service Market Size by Type
2.3.1 Drug Safety and Pharmacovigilance Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
2.4 Drug Safety and Pharmacovigilance Service Segment by Application
2.4.1 Experimental Stage
2.4.2 Clinical Stage
2.4.3 Postmarketing Stage
2.4.4 Other
2.5 Drug Safety and Pharmacovigilance Service Market Size by Application
2.5.1 Drug Safety and Pharmacovigilance Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
3 DRUG SAFETY AND PHARMACOVIGILANCE SERVICE MARKET SIZE BY PLAYER
3.1 Drug Safety and Pharmacovigilance Service Market Size Market Share by Players
3.1.1 Global Drug Safety and Pharmacovigilance Service Revenue by Players (2020-2022)
3.1.2 Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Players (2020-2022)
3.2 Global Drug Safety and Pharmacovigilance Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG SAFETY AND PHARMACOVIGILANCE SERVICE BY REGIONS
4.1 Drug Safety and Pharmacovigilance Service Market Size by Regions (2017-2022)
4.2 Americas Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.3 APAC Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.4 Europe Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022)
5.2 Americas Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
5.3 Americas Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022)
6.2 APAC Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
6.3 APAC Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance Service by Country (2017-2022)
7.2 Europe Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
7.3 Europe Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Safety and Pharmacovigilance Service by Region (2017-2022)
8.2 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG SAFETY AND PHARMACOVIGILANCE SERVICE MARKET FORECAST
10.1 Global Drug Safety and Pharmacovigilance Service Forecast by Regions (2023-2028)
10.1.1 Global Drug Safety and Pharmacovigilance Service Forecast by Regions (2023-2028)
10.1.2 Americas Drug Safety and Pharmacovigilance Service Forecast
10.1.3 APAC Drug Safety and Pharmacovigilance Service Forecast
10.1.4 Europe Drug Safety and Pharmacovigilance Service Forecast
10.1.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Forecast
10.2 Americas Drug Safety and Pharmacovigilance Service Forecast by Country (2023-2028)
10.2.1 United States Drug Safety and Pharmacovigilance Service Market Forecast
10.2.2 Canada Drug Safety and Pharmacovigilance Service Market Forecast
10.2.3 Mexico Drug Safety and Pharmacovigilance Service Market Forecast
10.2.4 Brazil Drug Safety and Pharmacovigilance Service Market Forecast
10.3 APAC Drug Safety and Pharmacovigilance Service Forecast by Region (2023-2028)
10.3.1 China Drug Safety and Pharmacovigilance Service Market Forecast
10.3.2 Japan Drug Safety and Pharmacovigilance Service Market Forecast
10.3.3 Korea Drug Safety and Pharmacovigilance Service Market Forecast
10.3.4 Southeast Asia Drug Safety and Pharmacovigilance Service Market Forecast
10.3.5 India Drug Safety and Pharmacovigilance Service Market Forecast
10.3.6 Australia Drug Safety and Pharmacovigilance Service Market Forecast
10.4 Europe Drug Safety and Pharmacovigilance Service Forecast by Country (2023-2028)
10.4.1 Germany Drug Safety and Pharmacovigilance Service Market Forecast
10.4.2 France Drug Safety and Pharmacovigilance Service Market Forecast
10.4.3 UK Drug Safety and Pharmacovigilance Service Market Forecast
10.4.4 Italy Drug Safety and Pharmacovigilance Service Market Forecast
10.4.5 Russia Drug Safety and Pharmacovigilance Service Market Forecast
10.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Forecast by Region (2023-2028)
10.5.1 Egypt Drug Safety and Pharmacovigilance Service Market Forecast
10.5.2 South Africa Drug Safety and Pharmacovigilance Service Market Forecast
10.5.3 Israel Drug Safety and Pharmacovigilance Service Market Forecast
10.5.4 Turkey Drug Safety and Pharmacovigilance Service Market Forecast
10.5.5 GCC Countries Drug Safety and Pharmacovigilance Service Market Forecast
10.6 Global Drug Safety and Pharmacovigilance Service Forecast by Type (2023-2028)
10.7 Global Drug Safety and Pharmacovigilance Service Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 BioPoint
11.1.1 BioPoint Company Information
11.1.2 BioPoint Drug Safety and Pharmacovigilance Service Product Offered
11.1.3 BioPoint Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 BioPoint Main Business Overview
11.1.5 BioPoint Latest Developments
11.2 Cmed
11.2.1 Cmed Company Information
11.2.2 Cmed Drug Safety and Pharmacovigilance Service Product Offered
11.2.3 Cmed Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cmed Main Business Overview
11.2.5 Cmed Latest Developments
11.3 Drug Safety Solutions
11.3.1 Drug Safety Solutions Company Information
11.3.2 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product Offered
11.3.3 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Drug Safety Solutions Main Business Overview
11.3.5 Drug Safety Solutions Latest Developments
11.4 Hilbrans
11.4.1 Hilbrans Company Information
11.4.2 Hilbrans Drug Safety and Pharmacovigilance Service Product Offered
11.4.3 Hilbrans Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Hilbrans Main Business Overview
11.4.5 Hilbrans Latest Developments
11.5 Orbis Clinical
11.5.1 Orbis Clinical Company Information
11.5.2 Orbis Clinical Drug Safety and Pharmacovigilance Service Product Offered
11.5.3 Orbis Clinical Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Orbis Clinical Main Business Overview
11.5.5 Orbis Clinical Latest Developments
11.6 Parexel
11.6.1 Parexel Company Information
11.6.2 Parexel Drug Safety and Pharmacovigilance Service Product Offered
11.6.3 Parexel Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Parexel Main Business Overview
11.6.5 Parexel Latest Developments
11.7 PharmaLex
11.7.1 PharmaLex Company Information
11.7.2 PharmaLex Drug Safety and Pharmacovigilance Service Product Offered
11.7.3 PharmaLex Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 PharmaLex Main Business Overview
11.7.5 PharmaLex Latest Developments
11.8 ProPharma
11.8.1 ProPharma Company Information
11.8.2 ProPharma Drug Safety and Pharmacovigilance Service Product Offered
11.8.3 ProPharma Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ProPharma Main Business Overview
11.8.5 ProPharma Latest Developments
11.9 SGS
11.9.1 SGS Company Information
11.9.2 SGS Drug Safety and Pharmacovigilance Service Product Offered
11.9.3 SGS Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 SGS Main Business Overview
11.9.5 SGS Latest Developments
11.10 SJ Pharma Consulting LLC
11.10.1 SJ Pharma Consulting LLC Company Information
11.10.2 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product Offered
11.10.3 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 SJ Pharma Consulting LLC Main Business Overview
11.10.5 SJ Pharma Consulting LLC Latest Developments
11.11 Vitrana
11.11.1 Vitrana Company Information
11.11.2 Vitrana Drug Safety and Pharmacovigilance Service Product Offered
11.11.3 Vitrana Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Vitrana Main Business Overview
11.11.5 Vitrana Latest Developments
11.12 X7 Research
11.12.1 X7 Research Company Information
11.12.2 X7 Research Drug Safety and Pharmacovigilance Service Product Offered
11.12.3 X7 Research Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 X7 Research Main Business Overview
11.12.5 X7 Research Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Safety and Pharmacovigilance Service Market Size 2017-2028
2.1.2 Drug Safety and Pharmacovigilance Service Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Safety and Pharmacovigilance Service Segment by Type
2.2.1 Drug Safety Service
2.2.2 Drug Pharmacovigilance Service
2.3 Drug Safety and Pharmacovigilance Service Market Size by Type
2.3.1 Drug Safety and Pharmacovigilance Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
2.4 Drug Safety and Pharmacovigilance Service Segment by Application
2.4.1 Experimental Stage
2.4.2 Clinical Stage
2.4.3 Postmarketing Stage
2.4.4 Other
2.5 Drug Safety and Pharmacovigilance Service Market Size by Application
2.5.1 Drug Safety and Pharmacovigilance Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
3 DRUG SAFETY AND PHARMACOVIGILANCE SERVICE MARKET SIZE BY PLAYER
3.1 Drug Safety and Pharmacovigilance Service Market Size Market Share by Players
3.1.1 Global Drug Safety and Pharmacovigilance Service Revenue by Players (2020-2022)
3.1.2 Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Players (2020-2022)
3.2 Global Drug Safety and Pharmacovigilance Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG SAFETY AND PHARMACOVIGILANCE SERVICE BY REGIONS
4.1 Drug Safety and Pharmacovigilance Service Market Size by Regions (2017-2022)
4.2 Americas Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.3 APAC Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.4 Europe Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022)
5.2 Americas Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
5.3 Americas Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022)
6.2 APAC Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
6.3 APAC Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance Service by Country (2017-2022)
7.2 Europe Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
7.3 Europe Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Safety and Pharmacovigilance Service by Region (2017-2022)
8.2 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG SAFETY AND PHARMACOVIGILANCE SERVICE MARKET FORECAST
10.1 Global Drug Safety and Pharmacovigilance Service Forecast by Regions (2023-2028)
10.1.1 Global Drug Safety and Pharmacovigilance Service Forecast by Regions (2023-2028)
10.1.2 Americas Drug Safety and Pharmacovigilance Service Forecast
10.1.3 APAC Drug Safety and Pharmacovigilance Service Forecast
10.1.4 Europe Drug Safety and Pharmacovigilance Service Forecast
10.1.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Forecast
10.2 Americas Drug Safety and Pharmacovigilance Service Forecast by Country (2023-2028)
10.2.1 United States Drug Safety and Pharmacovigilance Service Market Forecast
10.2.2 Canada Drug Safety and Pharmacovigilance Service Market Forecast
10.2.3 Mexico Drug Safety and Pharmacovigilance Service Market Forecast
10.2.4 Brazil Drug Safety and Pharmacovigilance Service Market Forecast
10.3 APAC Drug Safety and Pharmacovigilance Service Forecast by Region (2023-2028)
10.3.1 China Drug Safety and Pharmacovigilance Service Market Forecast
10.3.2 Japan Drug Safety and Pharmacovigilance Service Market Forecast
10.3.3 Korea Drug Safety and Pharmacovigilance Service Market Forecast
10.3.4 Southeast Asia Drug Safety and Pharmacovigilance Service Market Forecast
10.3.5 India Drug Safety and Pharmacovigilance Service Market Forecast
10.3.6 Australia Drug Safety and Pharmacovigilance Service Market Forecast
10.4 Europe Drug Safety and Pharmacovigilance Service Forecast by Country (2023-2028)
10.4.1 Germany Drug Safety and Pharmacovigilance Service Market Forecast
10.4.2 France Drug Safety and Pharmacovigilance Service Market Forecast
10.4.3 UK Drug Safety and Pharmacovigilance Service Market Forecast
10.4.4 Italy Drug Safety and Pharmacovigilance Service Market Forecast
10.4.5 Russia Drug Safety and Pharmacovigilance Service Market Forecast
10.5 Middle East & Africa Drug Safety and Pharmacovigilance Service Forecast by Region (2023-2028)
10.5.1 Egypt Drug Safety and Pharmacovigilance Service Market Forecast
10.5.2 South Africa Drug Safety and Pharmacovigilance Service Market Forecast
10.5.3 Israel Drug Safety and Pharmacovigilance Service Market Forecast
10.5.4 Turkey Drug Safety and Pharmacovigilance Service Market Forecast
10.5.5 GCC Countries Drug Safety and Pharmacovigilance Service Market Forecast
10.6 Global Drug Safety and Pharmacovigilance Service Forecast by Type (2023-2028)
10.7 Global Drug Safety and Pharmacovigilance Service Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 BioPoint
11.1.1 BioPoint Company Information
11.1.2 BioPoint Drug Safety and Pharmacovigilance Service Product Offered
11.1.3 BioPoint Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 BioPoint Main Business Overview
11.1.5 BioPoint Latest Developments
11.2 Cmed
11.2.1 Cmed Company Information
11.2.2 Cmed Drug Safety and Pharmacovigilance Service Product Offered
11.2.3 Cmed Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cmed Main Business Overview
11.2.5 Cmed Latest Developments
11.3 Drug Safety Solutions
11.3.1 Drug Safety Solutions Company Information
11.3.2 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product Offered
11.3.3 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Drug Safety Solutions Main Business Overview
11.3.5 Drug Safety Solutions Latest Developments
11.4 Hilbrans
11.4.1 Hilbrans Company Information
11.4.2 Hilbrans Drug Safety and Pharmacovigilance Service Product Offered
11.4.3 Hilbrans Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Hilbrans Main Business Overview
11.4.5 Hilbrans Latest Developments
11.5 Orbis Clinical
11.5.1 Orbis Clinical Company Information
11.5.2 Orbis Clinical Drug Safety and Pharmacovigilance Service Product Offered
11.5.3 Orbis Clinical Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Orbis Clinical Main Business Overview
11.5.5 Orbis Clinical Latest Developments
11.6 Parexel
11.6.1 Parexel Company Information
11.6.2 Parexel Drug Safety and Pharmacovigilance Service Product Offered
11.6.3 Parexel Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Parexel Main Business Overview
11.6.5 Parexel Latest Developments
11.7 PharmaLex
11.7.1 PharmaLex Company Information
11.7.2 PharmaLex Drug Safety and Pharmacovigilance Service Product Offered
11.7.3 PharmaLex Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 PharmaLex Main Business Overview
11.7.5 PharmaLex Latest Developments
11.8 ProPharma
11.8.1 ProPharma Company Information
11.8.2 ProPharma Drug Safety and Pharmacovigilance Service Product Offered
11.8.3 ProPharma Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ProPharma Main Business Overview
11.8.5 ProPharma Latest Developments
11.9 SGS
11.9.1 SGS Company Information
11.9.2 SGS Drug Safety and Pharmacovigilance Service Product Offered
11.9.3 SGS Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 SGS Main Business Overview
11.9.5 SGS Latest Developments
11.10 SJ Pharma Consulting LLC
11.10.1 SJ Pharma Consulting LLC Company Information
11.10.2 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product Offered
11.10.3 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 SJ Pharma Consulting LLC Main Business Overview
11.10.5 SJ Pharma Consulting LLC Latest Developments
11.11 Vitrana
11.11.1 Vitrana Company Information
11.11.2 Vitrana Drug Safety and Pharmacovigilance Service Product Offered
11.11.3 Vitrana Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Vitrana Main Business Overview
11.11.5 Vitrana Latest Developments
11.12 X7 Research
11.12.1 X7 Research Company Information
11.12.2 X7 Research Drug Safety and Pharmacovigilance Service Product Offered
11.12.3 X7 Research Drug Safety and Pharmacovigilance Service Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 X7 Research Main Business Overview
11.12.5 X7 Research Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Safety and Pharmacovigilance Service Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug Safety Service
Table 3. Major Players of Drug Pharmacovigilance Service
Table 4. Drug Safety and Pharmacovigilance Service Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 7. Drug Safety and Pharmacovigilance Service Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 10. Global Drug Safety and Pharmacovigilance Service Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Player (2020-2022)
Table 12. Drug Safety and Pharmacovigilance Service Key Players Head office and Products Offered
Table 13. Drug Safety and Pharmacovigilance Service Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Safety and Pharmacovigilance Service Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug Safety and Pharmacovigilance Service
Table 43. Key Market Challenges & Risks of Drug Safety and Pharmacovigilance Service
Table 44. Key Industry Trends of Drug Safety and Pharmacovigilance Service
Table 45. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Application (2023-2028)
Table 51. BioPoint Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 52. BioPoint Drug Safety and Pharmacovigilance Service Product Offered
Table 53. BioPoint Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. BioPoint Main Business
Table 55. BioPoint Latest Developments
Table 56. Cmed Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 57. Cmed Drug Safety and Pharmacovigilance Service Product Offered
Table 58. Cmed Main Business
Table 59. Cmed Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Cmed Latest Developments
Table 61. Drug Safety Solutions Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 62. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product Offered
Table 63. Drug Safety Solutions Main Business
Table 64. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Drug Safety Solutions Latest Developments
Table 66. Hilbrans Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 67. Hilbrans Drug Safety and Pharmacovigilance Service Product Offered
Table 68. Hilbrans Main Business
Table 69. Hilbrans Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Hilbrans Latest Developments
Table 71. Orbis Clinical Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 72. Orbis Clinical Drug Safety and Pharmacovigilance Service Product Offered
Table 73. Orbis Clinical Main Business
Table 74. Orbis Clinical Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Orbis Clinical Latest Developments
Table 76. Parexel Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 77. Parexel Drug Safety and Pharmacovigilance Service Product Offered
Table 78. Parexel Main Business
Table 79. Parexel Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Parexel Latest Developments
Table 81. PharmaLex Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 82. PharmaLex Drug Safety and Pharmacovigilance Service Product Offered
Table 83. PharmaLex Main Business
Table 84. PharmaLex Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. PharmaLex Latest Developments
Table 86. ProPharma Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 87. ProPharma Drug Safety and Pharmacovigilance Service Product Offered
Table 88. ProPharma Main Business
Table 89. ProPharma Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. ProPharma Latest Developments
Table 91. SGS Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 92. SGS Drug Safety and Pharmacovigilance Service Product Offered
Table 93. SGS Main Business
Table 94. SGS Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. SGS Latest Developments
Table 96. SJ Pharma Consulting LLC Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 97. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product Offered
Table 98. SJ Pharma Consulting LLC Main Business
Table 99. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. SJ Pharma Consulting LLC Latest Developments
Table 101. Vitrana Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 102. Vitrana Drug Safety and Pharmacovigilance Service Product Offered
Table 103. Vitrana Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Vitrana Main Business
Table 105. Vitrana Latest Developments
Table 106. X7 Research Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 107. X7 Research Drug Safety and Pharmacovigilance Service Product Offered
Table 108. X7 Research Main Business
Table 109. X7 Research Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. X7 Research Latest Developments
Table 1. Drug Safety and Pharmacovigilance Service Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug Safety Service
Table 3. Major Players of Drug Pharmacovigilance Service
Table 4. Drug Safety and Pharmacovigilance Service Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 7. Drug Safety and Pharmacovigilance Service Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 10. Global Drug Safety and Pharmacovigilance Service Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Player (2020-2022)
Table 12. Drug Safety and Pharmacovigilance Service Key Players Head office and Products Offered
Table 13. Drug Safety and Pharmacovigilance Service Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Safety and Pharmacovigilance Service Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug Safety and Pharmacovigilance Service
Table 43. Key Market Challenges & Risks of Drug Safety and Pharmacovigilance Service
Table 44. Key Industry Trends of Drug Safety and Pharmacovigilance Service
Table 45. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug Safety and Pharmacovigilance Service Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug Safety and Pharmacovigilance Service Market Size Market Share Forecast by Application (2023-2028)
Table 51. BioPoint Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 52. BioPoint Drug Safety and Pharmacovigilance Service Product Offered
Table 53. BioPoint Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. BioPoint Main Business
Table 55. BioPoint Latest Developments
Table 56. Cmed Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 57. Cmed Drug Safety and Pharmacovigilance Service Product Offered
Table 58. Cmed Main Business
Table 59. Cmed Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Cmed Latest Developments
Table 61. Drug Safety Solutions Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 62. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product Offered
Table 63. Drug Safety Solutions Main Business
Table 64. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Drug Safety Solutions Latest Developments
Table 66. Hilbrans Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 67. Hilbrans Drug Safety and Pharmacovigilance Service Product Offered
Table 68. Hilbrans Main Business
Table 69. Hilbrans Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Hilbrans Latest Developments
Table 71. Orbis Clinical Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 72. Orbis Clinical Drug Safety and Pharmacovigilance Service Product Offered
Table 73. Orbis Clinical Main Business
Table 74. Orbis Clinical Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Orbis Clinical Latest Developments
Table 76. Parexel Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 77. Parexel Drug Safety and Pharmacovigilance Service Product Offered
Table 78. Parexel Main Business
Table 79. Parexel Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Parexel Latest Developments
Table 81. PharmaLex Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 82. PharmaLex Drug Safety and Pharmacovigilance Service Product Offered
Table 83. PharmaLex Main Business
Table 84. PharmaLex Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. PharmaLex Latest Developments
Table 86. ProPharma Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 87. ProPharma Drug Safety and Pharmacovigilance Service Product Offered
Table 88. ProPharma Main Business
Table 89. ProPharma Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. ProPharma Latest Developments
Table 91. SGS Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 92. SGS Drug Safety and Pharmacovigilance Service Product Offered
Table 93. SGS Main Business
Table 94. SGS Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. SGS Latest Developments
Table 96. SJ Pharma Consulting LLC Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 97. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product Offered
Table 98. SJ Pharma Consulting LLC Main Business
Table 99. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. SJ Pharma Consulting LLC Latest Developments
Table 101. Vitrana Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 102. Vitrana Drug Safety and Pharmacovigilance Service Product Offered
Table 103. Vitrana Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Vitrana Main Business
Table 105. Vitrana Latest Developments
Table 106. X7 Research Details, Company Type, Drug Safety and Pharmacovigilance Service Area Served and Its Competitors
Table 107. X7 Research Drug Safety and Pharmacovigilance Service Product Offered
Table 108. X7 Research Main Business
Table 109. X7 Research Drug Safety and Pharmacovigilance Service Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. X7 Research Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Drug Safety and Pharmacovigilance Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 7. Drug Safety and Pharmacovigilance Service in Experimental Stage
Figure 8. Global Drug Safety and Pharmacovigilance Service Market: Experimental Stage (2017-2022) & ($ Millions)
Figure 9. Drug Safety and Pharmacovigilance Service in Clinical Stage
Figure 10. Global Drug Safety and Pharmacovigilance Service Market: Clinical Stage (2017-2022) & ($ Millions)
Figure 11. Drug Safety and Pharmacovigilance Service in Postmarketing Stage
Figure 12. Global Drug Safety and Pharmacovigilance Service Market: Postmarketing Stage (2017-2022) & ($ Millions)
Figure 13. Drug Safety and Pharmacovigilance Service in Other
Figure 14. Global Drug Safety and Pharmacovigilance Service Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 16. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Player in 2021
Figure 17. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug Safety and Pharmacovigilance Service Value Market Share by Country in 2021
Figure 23. Americas Drug Safety and Pharmacovigilance Service Consumption Market Share by Type in 2021
Figure 24. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 25. United States Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Region in 2021
Figure 30. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 31. China Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Country in 2021
Figure 38. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 39. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 40. Germany Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 48. Egypt Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 61. China Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 65. India Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 68. France Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Drug Safety and Pharmacovigilance Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 7. Drug Safety and Pharmacovigilance Service in Experimental Stage
Figure 8. Global Drug Safety and Pharmacovigilance Service Market: Experimental Stage (2017-2022) & ($ Millions)
Figure 9. Drug Safety and Pharmacovigilance Service in Clinical Stage
Figure 10. Global Drug Safety and Pharmacovigilance Service Market: Clinical Stage (2017-2022) & ($ Millions)
Figure 11. Drug Safety and Pharmacovigilance Service in Postmarketing Stage
Figure 12. Global Drug Safety and Pharmacovigilance Service Market: Postmarketing Stage (2017-2022) & ($ Millions)
Figure 13. Drug Safety and Pharmacovigilance Service in Other
Figure 14. Global Drug Safety and Pharmacovigilance Service Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 16. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Player in 2021
Figure 17. Global Drug Safety and Pharmacovigilance Service Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug Safety and Pharmacovigilance Service Value Market Share by Country in 2021
Figure 23. Americas Drug Safety and Pharmacovigilance Service Consumption Market Share by Type in 2021
Figure 24. Americas Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 25. United States Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Region in 2021
Figure 30. APAC Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 31. China Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Country in 2021
Figure 38. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 39. Europe Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 40. Germany Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Market Share by Application in 2021
Figure 48. Egypt Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug Safety and Pharmacovigilance Service Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 61. China Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 65. India Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 68. France Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug Safety and Pharmacovigilance Service Market Size 2023-2028 ($ Millions)
